CHARACTERIZATION OF THE CD48 GENE DEMONSTRATES A POSITIVE ELEMENT THAT IS SPECIFIC TO EPSTEIN-BARR VIRUS-IMMORTALIZED B-CELL LINES AND CONTAINS AN ESSENTIAL NF-KAPPA-B SITE

被引:22
作者
KLAMAN, LD [1 ]
THORLEYLAWSON, DA [1 ]
机构
[1] TUFTS UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02111 USA
关键词
D O I
10.1128/JVI.69.2.871-881.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Epstein-Barr virus (EBV) infection of mature, resting B cells drives them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells, Here, we report on the identification of an enhancer element in the CD48 gene which reproducibIy confers strong transcriptional activity only in EBV-positive B-lymphoblastoid cell lines. The element is not activated upon infection of established EBV-negative B-cell lines, indicating that EBV fails to drive these cells to a fully lymphoblastoid phenotype. An NF-kappa B binding site is an essential component of the element but alone is not sufficient to account for the activity or the specificity of the element. We have detected a specific nuclear protein complex that binds to the element and show that NF-kappa B1 (p50) is a part of this complex. The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.
引用
收藏
页码:871 / 881
页数:11
相关论文
共 45 条
[31]   ALL 3 DOMAINS OF THE EPSTEIN-BARR VIRUS-ENCODED LATENT MEMBRANE-PROTEIN LMP-1 ARE REQUIRED FOR TRANSFORMATION OF RAT-1 FIBROBLASTS [J].
MOORTHY, RK ;
THORLEYLAWSON, DA .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1638-1646
[32]   BIOCHEMICAL, GENETIC, AND FUNCTIONAL ANALYSES OF THE PHOSPHORYLATION SITES ON THE EPSTEIN-BARR VIRUS-ENCODED ONCOGENIC LATENT MEMBRANE-PROTEIN LMP-1 [J].
MOORTHY, RK ;
THORLEYLAWSON, DA .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2637-2645
[33]  
POPE JH, 1979, EPSTEINBARR VIRUS, P205
[34]  
ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704
[35]   EARLY EVENTS IN EPSTEIN-BARR VIRUS-INFECTION PROVIDE A MODEL FOR B-CELL ACTIVATION [J].
THORLEYLAWSON, DA ;
MANN, KP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :45-59
[36]  
THORLEYLAWSON DA, 1985, J IMMUNOL, V134, P3007
[37]   EPSTEIN-BARR VIRUS SUPERINDUCES A NEW HUMAN B-CELL DIFFERENTIATION ANTIGEN (B-LAST-1) EXPRESSED ON TRANSFORMED LYMPHOBLASTS [J].
THORLEYLAWSON, DA ;
SCHOOLEY, RT ;
BHAN, AK ;
NADLER, LM .
CELL, 1982, 30 (02) :415-425
[38]  
THORLEYLAWSON DA, UNPUB
[39]  
TOMPKINSON B, 1993, J VIROL, V67, P2014
[40]   AN EBV MEMBRANE-PROTEIN EXPRESSED IN IMMORTALIZED LYMPHOCYTES TRANSFORMS ESTABLISHED RODENT CELLS [J].
WANG, D ;
LIEBOWITZ, D ;
KIEFF, E .
CELL, 1985, 43 (03) :831-840